3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines

US9688699B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Alexandros Vakalopoulos · Hilden, DE
• Alexey GROMOV · Erkrath, DE
• Markus Follmann
• Damian Brockschnieder · Haan, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Tobias Marquardt · Wuppertal, DE
• Adrian Tersteegen · Wuppertal, DE
• Frank Wunder · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Dieter Lang · Velbert, DE
• Volkhart Min-Jian Li · Velbert, DE

Key dates

• Filing date: Feb 17, 2015
• Grant date: Jun 27, 2017
• Expiry date: Feb 17, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel 3-(pyrimidin-2-yl)imidazo[1,2-a]pyridines, to processes for preparation thereof, to the use thereof, alone or in combinations, for the treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular disorders.